+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rofecoxib"

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Rofecoxib is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is a member of the coxib class of drugs, which are selective inhibitors of the enzyme cyclooxygenase-2 (COX-2). Rofecoxib is used to treat mild to moderate pain, including menstrual cramps, osteoarthritis, and rheumatoid arthritis. It is also used to reduce fever and to treat acute pain. Rofecoxib is available in tablet form and is taken orally. Rofecoxib is one of the most widely used analgesics in the world. It is used to treat a variety of conditions, including pain, inflammation, and fever. It is generally well tolerated and has few side effects. However, it has been linked to an increased risk of cardiovascular events, such as heart attack and stroke. As a result, it has been withdrawn from the market in many countries. Some of the companies in the Rofecoxib market include Merck & Co., Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more